If people haven't done there research and are buying based on HC forum or based on covid trial results then agree there is argument there but way she put it out there didn't come across that way from the way I read it.
anyway For me her opinion doesn't matter at end of day. Because I know the risk and pros and cons of investing in MSB. So I will stick to it
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-221
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.035(2.99%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $3.050M | 2.574M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 12118 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 28046 | 2 |
View Market Depth
| Last trade - 12.27pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |